Skip to main content
. 2020 May 19;83(2):674–675. doi: 10.1016/j.jaad.2020.05.073

Table I.

Main epidemiologic and clinical characteristics of the study population

Variables Patients Total
Patients with COVID-19 (pharyngeal swab-positive) 678
 Italian patients 92
 Chinese patients 586
Degree of disease severity
 Critical types 41 (6)
 Severe types 118 (17.5)
 Common types 127 (18.7)
 Mild types 392 (57.8)
Patients with COVID19 with skin manifestations 53 (7.8)
 Male 32 (60)
 Female 21 (40)
Age, y 55.9 (28-69)
 Chinese patients 53.2 (28-65)
 Italian patients 58.6 (35-69)
Inflammatory skin manifestations related to COVID-19 53
 Erythematous rash 37 (70)
 Diffuse urticaria 14 (26)
 Varicelliform rash with vesiculation 2 (4)
Vascular skin manifestations in intensive care patients
 Diffuse petechiae, purpura, and acroischemia 13
Onset of inflammatory skin manifestations related to COVID-19 53
 Before hospitalization 23 (44)
 After hospitalization 30 (56)
Duration of inflammatory skin manifestations, d 3 (2-5)

COVID-19, Coronavirus disease 2019.

Patient data are presented as number (%) or mean (range).

Degree of disease severity: For the mild type: slight clinical symptoms with no pneumonia presentation in imaging. For the common type: manifestations such as fever or respiratory presentation with pneumonia by radiography, or both. For the severe type (meeting any of the following conditions): (1) dyspnea, respiration rate 30 times/min; (2) finger oxygen saturation under resting 93%; (3) arterial partial pressure of arterial oxygen/fraction of inspired oxygen 300 mm Hg (1 mm Hg = 0.133 kPa). For the critical type (meeting any of the following conditions): (1) respiratory failure requiring mechanical ventilation; (2) shock; (3) combined with other organ failures requiring an intensive care unit.